Object.assign(window.diseases, {
     cns_infections: {
        name: 'Central Nervous System Infections',
        icon: 'ðŸ§ ',
        color: '#0891b2',
        diseases: [
          {
            id: 'csf_differential',
            name: 'Differential Diagnosis of CSF Findings',
            table: {
              headers: ['Parameter', 'Bacterial', 'Viral', 'Normal'],
              rows: [
                ['Opening Pressure', 'Elevated (>20 cmH2O)', 'Normal or slightly elevated', '6-20 cmH2O'],
                ['Appearance', 'Cloudy, purulent', 'Clear ("water-clear")', 'Clear, colorless'],
                ['Cell Count (WBC/ÂµL)', '>1000 (often 100-10000)', '10-500 (rarely >1000)', '0-5'],
                ['Dominant Cell', 'Neutrophils (>80%)', 'Lymphocytes (PMN may be early!)', 'Lymphocytes/Monocytes'],
                ['Protein (g/L)', 'Elevated (>1 g/L)', 'Normal or slightly elevated (<1 g/L)', '0.15-0.45 g/L'],
                ['Glucose (mmol/L)', 'Decreased (<2.2 mmol/L)', 'Normal (>2.5 mmol/L)', '2.5-4.4 mmol/L'],
                ['CSF/Blood Glucose Ratio', '< 0.4', '> 0.6', 'â‰¥ 0.6'],
                ['Lactate', 'Elevated (>3.5 mmol/L)', 'Normal (<3.5 mmol/L)', '< 2.5 mmol/L'],
                ['Microbiology', 'Gram stain (+ 60-90%), Culture (+)', 'PCR (+), Gram/Culture negative', 'Negative']
              ]
            }
          },
          {
            id: 'bacterial_meningitis',
            name: 'Bacterial Meningitis (Empiric)',
            pathogen: { type: 'Bacterium', name: '<i>N. meningitidis, S. pneumoniae, L. monocytogenes</i>', gram: 'Mixed', shape: 'Pathogen dependent' },
            epidemiology: {
              incidence: '2-5/100,000 per year in developed countries',
              risk_groups: ['Neonates (<1 month)', 'Children', 'Adults >65 years', 'Asplenic patients', 'Complement deficiency', 'Cochlear implant recipients'],
              seasonality: 'Meningococcus: Winter-Spring',
              transmission: 'Droplet (Meningococcus), Endogenous (Pneumococcus), Vertical (GBS, Listeria)'
            },
            pathomechanism: {
              steps: [
                'Colonization and Invasion: Pathogens (e.g., Meningococcus, Pneumococcus) colonize the nasopharyngeal mucosa and invade the bloodstream (bacteremia).',
                'Crossing the Blood-Brain Barrier: Bacteria cross the endothelium of the choroid plexus or cerebral capillaries to enter the subarachnoid space.',
                'Replication and Inflammation: Bacteria multiply rapidly in the CSF (which lacks humoral immunity). Bacterial cell wall components (LPS, teichoic acid) trigger a massive inflammatory response via PRRs (cytokines: TNF-Î±, IL-1Î²).',
                'Cerebral Edema and ICP: Inflammation increases BBB permeability (vasogenic edema), reduces CSF absorption (interstitial edema), and causes cell swelling (cytotoxic edema).',
                'Consequence: The resulting cerebral edema raises intracranial pressure (ICP), reducing cerebral perfusion pressure (CPP), leading to ischemia and neuronal damage.'
              ],
              virulence_factors: ['Polysaccharide capsule', 'IgA protease', 'Lipooligosaccharide (LOS)', 'Pili/fimbriae']
            },
            clinical: {
              incubation: '2-10 days (Meningococcus), shorter (Pneumococcus)',
              onset: 'Acute (hours-days)',
              symptoms: [
                { name: 'Classic Triad', description: 'The classic triad (fever, nuchal rigidity, altered mental status) is present in <50% of patients. Headache (severe, diffuse) and fever are the most common (95%).', severity: 'severe' },
                { name: 'Meningeal Signs', description: 'Nuchal rigidity (chin cannot touch chest), Kernig\'s sign (pain on leg extension with hip flexed), and Brudzinski\'s sign (legs lift when head is raised).', severity: 'moderate' },
                { name: 'Systemic "Red Flags"', description: 'Especially in Meningococcus: leg pain, cold hands/feet, mottled skin - these are early signs of sepsis preceding meningitis symptoms.', severity: 'severe' },
                { name: 'Rash', description: 'In Meningococcemia: petechiae (tiny bleeds) or purpura (larger bleeds) that do not fade under pressure (non-blanching rash).', severity: 'severe' },
                { name: 'Neurological Symptoms', description: 'Altered mental status (confusion to coma), seizures (20-30%), cranial nerve palsies (III, IV, VI, VII, VIII), and focal signs.', severity: 'severe' }
              ],
              physical_exam: [
                'Meningeal signs: Kernig (+), Brudzinski (+), nuchal rigidity',
                'Fever (often >39Â°C)',
                'Altered mental status (decreased GCS)',
                'Focal neurological deficits (cranial nerve palsy, paresis)',
                'Petechiae/purpura (Meningococcemia)',
                'Papilledema (late sign)'
              ],
              complications: ['Septic shock', 'DIC', 'ARDS', 'Cerebral edema/herniation', 'Subdural empyema', 'Hearing loss', 'Cognitive impairment']
            },
            diagnostics: {
              laboratory: [
                { test: 'CBC', finding: 'Leukocytosis (15-30 G/L) with left shift', interpretation: 'Bacterial infection' },
                { test: 'CRP/PCT', finding: 'Significantly elevated (PCT >2)', interpretation: 'Bacterial sepsis' },
                { test: 'Blood PCR', finding: 'Meningococcus/Pneumococcus DNA', interpretation: 'NICE recommendation: take in all suspected cases!' },
                { test: 'Coagulation profile', finding: 'Signs of DIC (â†“fibrinogen, â†‘D-dimer)', interpretation: 'Meningococcus' }
              ],
              imaging: [
                { modality: 'CT Head', finding: 'Exclude contraindications', significance: 'Indicated before LP if: GCS <9, seizures, focal signs, papilledema' },
                { modality: 'MRI', finding: 'More sensitive for complications', significance: 'Empyema, infarction' }
              ],
              microbiology: [
                { test: 'CSF Analysis', finding: 'WBC >1000/ÂµL (PMN), Protein >1 g/L, Glucose <40% of serum', significance: 'Typical for bacterial meningitis' },
                { test: 'CSF Lactate', finding: 'Elevated', significance: 'Helps differentiate from viral' },
                { test: 'CSF Gram Stain', finding: '60-90% positive', significance: 'Quick orientation' },
                { test: 'CSF/Blood Culture', finding: 'Pathogen isolation', significance: 'Antimicrobial susceptibility testing' },
                { test: 'CSF PCR (Multiplex)', finding: 'DNA detection', significance: 'Fast, sensitive, useful in pre-treated patients' },
                { test: 'CSF Latex Agglutination', finding: 'Antigen detection', significance: 'Fast, less sensitive' }
              ]
            },
            differential: [
              { disease: 'Viral Meningitis', distinguishing: 'Milder course, CSF: lymphocytes, normal glucose' },
              { disease: 'Tuberculous Meningitis', distinguishing: 'Subacute, low glucose, basilar meningitis' },
              { disease: 'Encephalitis', distinguishing: 'Altered mental status dominates, focal signs, milder CSF changes' },
              { disease: 'Subarachnoid Hemorrhage', distinguishing: 'Thunderclap headache, bloody/xanthochromic CSF' },
              { disease: 'Meningeal Carcinomatosis', distinguishing: 'Malignancy history, cytology' }
            ],
            therapy: {
              guidelines: ['NICE NG240 (2024): Meningitis (bacterial) and meningococcal disease'],
              empirical: {
                outpatient: [
                  { drug: 'Benzylpenicillin or Ceftriaxone', dose: 'IM/IV stat', duration: 'Single dose', note: 'Only if hospital transfer is significantly delayed (NICE)' }
                ],
                inpatient: [
                  { drug: 'Ceftriaxone', dose: '2 g IV every 12 hours (or 4 g once daily)', duration: 'Pathogen dependent', note: 'First choice (NICE). Alternative: Cefotaxime.' },
                  { drug: '+ Ampicillin', dose: '2 g IV every 4 hours', duration: 'Pathogen dependent', note: 'If Listeria risk (>60 years, immunocompromised, pregnancy).' },
                  { drug: 'Dexamethasone', dose: '10 mg IV every 6 hours', duration: '4 days', note: 'Administer BEFORE or WITH the first antibiotic dose. Avoid in septic shock without meningitis.' }
                ],
                icu: [
                  { drug: 'Supportive Care', dose: '-', duration: '-', note: 'Airway protection, fluid resuscitation, vasopressors' }
                ]
              },
              targeted: 'N. meningitidis: 7 days; S. pneumoniae: 14 days; L. monocytogenes: 21 days; H. influenzae: 10 days; S. agalactiae (GBS): 14-21 days.',
              supportive: ['Fluid and electrolyte management', 'Intracranial pressure (ICP) monitoring', 'Seizure management', 'Droplet isolation (for Meningococcus, until 24h of effective antibiotics)'],
              prevention: ['Meningococcal vaccines (MenACWY, MenB)', 'Pneumococcal vaccines (PCV, PPSV)', 'Hib vaccine', 'Chemoprophylaxis for close contacts (Rifampicin, Ciprofloxacin, or Ceftriaxone)']
            },
            prognosis: {
              mortality: 'Overall 15-25% (Meningococcus ~10%, Pneumococcus 20-30%, Listeria 20-30%)',
              prognostic_scores: ['Glasgow Coma Scale', 'APACHE II Score'],
              factors: 'Age, pathogen virulence, time to treatment, level of consciousness, seizures, presence of shock'
            }
          },
          {
            id: 'meningococcal_meningitis',
            name: 'Meningococcal Meningitis',
            pathogen: { type: 'Bacterium', name: '<i>Neisseria meningitidis</i>', gram: 'Gram-negative', shape: 'diplococcus' },
            epidemiology: {
              incidence: 'Can be epidemic',
              risk_groups: ['Infants', 'Adolescents', 'Closed communities (dorms)', 'Asplenia'],
              seasonality: 'Winter-Spring',
              transmission: 'Droplet (close contact)'
            },
            pathomechanism: {
              steps: [
                'The bacterium colonizes the nasopharynx and enters the bloodstream.',
                'Rapid replication in blood releases massive amounts of endotoxin (LOS) (meningococcemia).',
                'Endotoxin triggers systemic inflammation, vasculitis, and disseminated intravascular coagulation (DIC).',
                'This leads to small vessel occlusion (skin necrosis, adrenal hemorrhage - Waterhouse-Friderichsen syndrome) and septic shock, often before meningitis develops.'
              ],
              virulence_factors: ['Capsule (A,B,C,W,Y)', 'LOS (Lipooligosaccharide)', 'IgA protease']
            },
            clinical: {
              incubation: '1-10 days',
              onset: 'Hyperacute',
              symptoms: [
                { name: 'Hyperacute Onset', description: 'Patient condition deteriorates dramatically within hours. Fever, vomiting, headache are early signs.', severity: 'severe' },
                { name: 'Hemorrhagic Rash', description: 'Initially blanching macules, rapidly evolving into petechiae and purpura that DO NOT fade under pressure (non-blanching rash). Sign of meningococcemia.', severity: 'severe' },
                { name: 'Septic Shock', description: 'Cold extremities, cyanosis, low blood pressure, rapid pulse, anuria.', severity: 'severe' }
              ],
              physical_exam: ['Meningeal signs', 'Purpura', 'Signs of shock'],
              complications: ['Limb necrosis/amputation', 'Deafness', 'Death (within hours)']
            },
            diagnostics: {
              laboratory: [{ test: 'CSF', finding: 'Purulent', interpretation: '-' }, { test: 'PCR', finding: 'Positive', interpretation: 'Rapid' }],
              microbiology: [{ test: 'Gram stain', finding: 'Gram-negative diplococci', significance: 'Rapid' }]
            },
            therapy: {
              empirical: { inpatient: [{ drug: 'Ceftriaxone', dose: '2g IV every 12 hours', duration: '7 days', note: 'NICE NG240 recommendation' }] },
              targeted: 'Ceftriaxone for 7 days. Prophylaxis for contacts: Ciprofloxacin (single 500mg PO) or Rifampicin.',
              supportive: [],
              prevention: ['Vaccination (MenACWY, MenB)']
            },
            prognosis: { mortality: '10-15% even with treatment', prognostic_scores: [], factors: 'Age, comorbidity, time to treatment' }
          },
          {
            id: 'pneumococcal_meningitis',
            name: 'Pneumococcal Meningitis',
            pathogen: { type: 'Bacterium', name: '<i>Streptococcus pneumoniae</i>', gram: 'Gram-positive', shape: 'diplococcus' },
            epidemiology: {
              incidence: 'Most common adult meningitis',
              risk_groups: ['Elderly', 'Alcoholics', 'Splenectomy', 'Otitis/Sinusitis/Pneumonia', 'CSF leak'],
              seasonality: 'Winter',
              transmission: 'Endogenous spread or droplet'
            },
            pathomechanism: {
              steps: [
                'Infection often spreads to meninges from an adjacent focus (otitis media, sinusitis, mastoiditis) or via bacteremia accompanying pneumonia.',
                'The pneumococcal capsule inhibits phagocytosis, and pneumolysin toxin directly damages cells and stimulates inflammation.',
                'This pathogen causes the most severe purulent meningitis, with frequent coma and permanent sequelae.'
              ],
              virulence_factors: ['Capsule', 'Pneumolysin']
            },
            clinical: {
              incubation: 'Short',
              onset: 'Acute',
              symptoms: [
                { name: 'Severe Meningitis', description: 'Characterized by rapid onset of altered consciousness, coma, and seizures. Mortality and sequelae rates are highest in this type.', severity: 'severe' },
                { name: 'Predisposing Signs', description: 'Concurrent pneumonia, otitis media, or sinusitis is often found.', severity: 'moderate' }
              ],
              physical_exam: ['Meningeal signs', 'Signs of otitis media', 'Altered mental status'],
              complications: ['Deafness', 'Hydrocephalus', 'Brain abscess']
            },
            diagnostics: {
              laboratory: [{ test: 'CSF', finding: 'Purulent, very high protein, low sugar', interpretation: '-' }],
              microbiology: [{ test: 'Gram stain', finding: 'Gram-positive diplococci', significance: '-' }]
            },
            therapy: {
              empirical: { inpatient: [{ drug: 'Ceftriaxone', dose: '2g IV every 12 hours', duration: '14 days', note: 'NICE NG240 recommendation' }, { drug: 'Dexamethasone', dose: '10mg IV every 6 hours', duration: '4 days', note: 'Continue if Pneumococcus is confirmed!' }] },
              targeted: 'Ceftriaxone for 14 days. If resistance confirmed: + Vancomycin/Rifampicin.',
              supportive: [],
              prevention: ['Pneumococcal vaccine (PCV, PPSV)']
            },
            prognosis: { mortality: '20-30%, high morbidity', prognostic_scores: [], factors: 'Age, immune status' }
          },
          {
            id: 'listeria_meningitis',
            name: 'Listeria Meningitis',
            pathogen: { type: 'Bacterium', name: '<i>Listeria monocytogenes</i>', gram: 'Gram-positive', shape: 'rod' },
            epidemiology: {
              incidence: 'Rare but dangerous',
              risk_groups: ['Neonates', 'Elderly (>50 years)', 'Pregnant women', 'Immunocompromised (transplant, alcoholic)'],
              seasonality: 'None',
              transmission: 'Food (soft cheese, cold cuts)'
            },
            pathomechanism: {
              steps: [
                'Bacteria enter via contaminated food, penetrate the gut wall, and enter the bloodstream.',
                'It has a specific tropism for the brainstem (rhombencephalon) and meninges.',
                'As an intracellular pathogen, it spreads cell-to-cell, evading antibodies. Cellular immunity is crucial (which is weaker in infants, elderly, pregnant).',
                'Forms microabscesses and granulomas in the brainstem.'
              ],
              virulence_factors: ['Intracellular survival', 'Listeriolysin O']
            },
            clinical: {
              incubation: '1-4 weeks',
              onset: 'Subacute',
              symptoms: [
                { name: 'Subacute Course', description: 'Symptoms may develop more slowly over days to weeks, not as stormy as other bacterial meningitides.', severity: 'moderate' },
                { name: 'Rhombencephalitis', description: 'Signs of brainstem involvement: cranial nerve palsies (e.g., facial weakness, swallowing difficulty), ataxia, nystagmus, and respiratory distress.', severity: 'severe' },
                { name: 'Lack of Signs', description: 'Nuchal rigidity is often absent; only fever and confusion may be noted.', severity: 'severe' }
              ],
              physical_exam: ['Meningeal signs (may be absent)', 'Focal signs'],
              complications: ['Brain abscess', 'Hydrocephalus']
            },
            diagnostics: {
              laboratory: [{ test: 'CSF', finding: 'Can be lymphocytic! (not always PMN)', interpretation: 'Misleading' }],
              microbiology: [{ test: 'Gram stain', finding: 'Often negative or Gram+ rods (can be mistaken for diphtheroids)', significance: '-' }]
            },
            therapy: {
              empirical: { inpatient: [{ drug: 'Amoxicillin / Ampicillin', dose: '2g IV every 4 hours', duration: '21 days', note: 'NICE NG240 recommendation. Cephalosporins are INEFFECTIVE!' }, { drug: '+ Gentamicin', dose: '5mg/kg IV once daily', duration: 'First 7 days', note: 'Synergistic effect' }] },
              targeted: 'Amoxicillin/Ampicillin (21 days) + Gentamicin (first 7 days). In penicillin allergy: Cotrimoxazole (Trimethoprim/Sulfamethoxazole).',
              supportive: [],
              prevention: ['Food hygiene in risk groups']
            },
            prognosis: { mortality: '20-30%', prognostic_scores: [], factors: 'Age, immune status' }
          },
          {
            id: 'aseptic_meningitis',
            name: 'Aseptic (Viral) Meningitis',
            pathogen: { type: 'Virus', name: 'Enteroviruses (<i>Coxsackie, Echo</i>), <i>HSV-2, VZV</i>', gram: 'RNA/DNA', shape: '-' },
            epidemiology: {
              incidence: 'Most common form of meningitis',
              risk_groups: ['Children', 'Young adults'],
              seasonality: 'Summer-Autumn (Enterovirus)',
              transmission: 'Fecal-oral (Entero), Sexual (HSV-2)'
            },
            pathomechanism: {
              steps: [
                'The virus (e.g., Enterovirus) enters the bloodstream from the gut or respiratory tract (viremia).',
                'It crosses the blood-brain barrier to infect the meninges and choroid plexus.',
                'It triggers an inflammatory response (mainly lymphocytic), but unlike bacterial infection, no purulent exudate forms, and the brain parenchyma is usually spared (hence clear consciousness).',
                'The process is usually self-limiting; the immune system clears the infection.'
              ],
              virulence_factors: ['-']
            },
            clinical: {
              incubation: '3-7 days',
              onset: 'Sudden',
              symptoms: [
                { name: 'Meningeal Syndrome', description: 'Headache (frontal/retro-orbital), fever, photophobia, and nuchal rigidity.', severity: 'moderate' },
                { name: 'Clear Consciousness', description: 'The most important differential sign: the patient is alert, oriented, with no focal neurological deficits (unlike encephalitis or bacterial meningitis).', severity: 'mild' },
                { name: 'Systemic Symptoms', description: 'Rash, sore throat, diarrhea may accompany Enterovirus; genital lesions with HSV-2.', severity: 'mild' }
              ],
              physical_exam: ['Meningeal signs (milder)', 'Consciousness clear (difference from encephalitis!)'],
              complications: ['Rare (Meningoencephalitis)']
            },
            diagnostics: {
              laboratory: [{ test: 'CSF', finding: 'Lymphocytic pleocytosis (tens-hundreds), normal glucose, slightly elevated protein', interpretation: 'Viral profile' }],
              microbiology: [{ test: 'CSF PCR', finding: 'Enterovirus/HSV/VZV', significance: 'Diagnostic' }]
            },
            therapy: {
              empirical: { outpatient: [{ drug: 'Supportive', dose: '-', duration: '-', note: 'Pain relief, Rest' }] },
              targeted: 'Consider Acyclovir for HSV-2/VZV (especially in immunocompromised). Enterovirus: symptomatic.',
              supportive: [],
              prevention: ['Hygiene']
            },
            prognosis: { mortality: 'Excellent, spontaneous recovery', prognostic_scores: [], factors: 'None' }
          },
          {
            id: 'viral_encephalitis',
            name: 'Viral Encephalitis',
            pathogen: { type: 'Virus', name: '<i>HSV-1, VZV</i>, Enteroviruses, Arboviruses', gram: 'DNA/RNA viruses', shape: 'variable' },
            epidemiology: {
              incidence: '0.5-7/100,000 per year',
              risk_groups: ['Neonates (HSV-2)', 'Immunocompromised patients', 'Elderly (VZV reactivation)', 'Travelers to endemic areas (Arboviruses)'],
              seasonality: 'Enterovirus: Summer-Autumn; HSV: Year-round',
              transmission: 'HSV: Reactivation/Primary; Enterovirus: Fecal-oral; Arbovirus: Vector-borne (Mosquito/Tick)'
            },
            pathomechanism: {
              steps: [
                'Entry: Viruses reach the CNS via hematogenous spread (e.g., Arboviruses) or neural pathways (e.g., HSV, Rabies).',
                'Neurotropism: Viruses directly infect neurons and glial cells. HSV-1 specifically targets the temporal and frontal lobes (via olfactory or trigeminal routes).',
                'Mechanism of Injury: Neuronal death is caused by direct viral cytopathic effects and the host\'s cytotoxic T-cell immune response.',
                'Histology: Perivascular lymphocytic infiltration, neuronophagia, and microglial nodules. HSV causes hemorrhagic necrosis.',
                'Consequence: Cerebral edema, inflammation, hemorrhage, and extensive neuronal death leading to focal deficits and altered consciousness.'
              ],
              virulence_factors: ['HSV: Glycoproteins (gB, gC, gD) for cell entry', 'VZV: Latency in sensory ganglia', 'Enterovirus: Capsid proteins']
            },
            clinical: {
              incubation: 'HSV variable; Enterovirus 3-7 days; Arbovirus 4-14 days',
              onset: 'Acute to Subacute',
              symptoms: [
                { name: 'Altered Mental Status (Hallmark)', description: 'The key distinguishing feature from meningitis: the patient is not alert/oriented. Manifests as confusion, lethargy, personality changes, or coma.', severity: 'severe' },
                { name: 'Fever and Headache', description: 'Almost always present (>90%), often accompanied by nausea and vomiting.', severity: 'moderate' },
                { name: 'Focal Neurological Deficits', description: 'Depending on the affected area: hemiparesis, aphasia, ataxia, cranial nerve palsies.', severity: 'severe' },
                { name: 'Seizures', description: 'Common (especially in HSV and autoimmune causes), can be focal or generalized.', severity: 'severe' },
                { name: 'Psychiatric Symptoms', description: 'Hallucinations, agitation, psychosis, memory loss - especially in forms affecting the limbic system (e.g., HSV).', severity: 'severe' }
              ],
              physical_exam: [
                'Decreased level of consciousness (GCS)',
                'Focal signs (Hemiparesis, CN palsies)',
                'Seizures (Focal or Generalized)',
                'Meningeal signs (often mild/moderate)',
                'Papilledema (signs of raised ICP)'
              ],
              complications: ['Permanent neurological sequelae', 'Post-encephalitic epilepsy', 'Motor/Cognitive deficits', 'Death (Untreated HSV mortality ~70%)']
            },
            diagnostics: {
              laboratory: [
                { test: 'CBC', finding: 'Variable (Leukocytosis or Normal)', interpretation: 'Non-specific' },
                { test: 'CRP', finding: 'Normal or Moderately elevated', interpretation: 'Usually lower than in bacterial meningitis' },
                { test: 'Renal/Liver function', finding: 'Baseline assessment', interpretation: 'Monitor for Acyclovir nephrotoxicity' }
              ],
              imaging: [
                { modality: 'MRI Brain', finding: 'HSV: Asymmetric hyperintensity in temporal/frontal lobes (T2/FLAIR)', significance: 'Gold standard imaging. Perform early.' },
                { modality: 'CT Head', finding: 'Often normal in early stages', significance: 'To exclude mass effect before LP' }
              ],
              microbiology: [
                { test: 'CSF PCR', finding: 'HSV-1/2, VZV, Enterovirus, Arbovirus', significance: 'Gold standard. False negative possible in first 24-48h.' },
                { test: 'CSF Analysis', finding: 'Lymphocytic pleocytosis (10-500 cells/ÂµL), Protein normal/mildly elevated, Glucose normal', significance: 'Viral profile' },
                { test: 'CSF Erythrocytes', finding: 'Elevated RBCs, Xanthochromia', significance: 'Suggests hemorrhagic necrosis (HSV)' },
                { test: 'Serology (Serum/CSF)', finding: 'IgM or 4-fold IgG rise (Arboviruses)', significance: 'Often retrospective' }
              ]
            },
            differential: [
              { disease: 'Bacterial Meningitis', distinguishing: 'More acute, CSF: PMN predominance, Hypoglycorrhachia' },
              { disease: 'Autoimmune Encephalitis', distinguishing: 'Subacute, psychiatric features, Anti-NMDA-R antibodies' },
              { disease: 'Brain Abscess', distinguishing: 'Imaging: Ring-enhancing lesion' },
              { disease: 'Toxic-Metabolic Encephalopathy', distinguishing: 'Metabolic derangements, Toxins, No fever/pleocytosis' },
              { disease: 'Non-convulsive Status Epilepticus', distinguishing: 'EEG diagnostic' }
            ],
            therapy: {
              empirical: {
                outpatient: [
                  { drug: 'No outpatient treatment', dose: 'Immediate hospitalization', duration: '', note: 'High mortality without treatment' }
                ],
                inpatient: [
                  { drug: 'Acyclovir', dose: '10 mg/kg IV every 8 hours', duration: '14-21 days', note: 'Start empirically if HSV suspected' }
                ],
                icu: [
                  { drug: 'Acyclovir', dose: '10 mg/kg IV every 8 hours', duration: '21 days', note: 'For immunocompromised or severe cases' },
                  { drug: 'Anticonvulsants', dose: 'e.g., Levetiracetam', duration: '', note: 'For seizure control' }
                ]
              },
              targeted: 'HSV/VZV: Acyclovir; CMV: Ganciclovir/Foscarnet; Enterovirus: Supportive',
              supportive: ['ICP Management', 'Seizure Control', 'Fluid/Electrolyte Balance', 'Rehabilitation'],
              prevention: ['VZV Vaccination', 'Vector control (Arboviruses)', 'C-section for active genital herpes to prevent Neonatal HSV']
            },
            prognosis: {
              mortality: 'HSV untreated >70%, treated ~20-30%; Enterovirus <1%',
              prognostic_scores: ['GCS at presentation', 'Age'],
              factors: 'Time to Acyclovir, Age, GCS, Viral load'
            }
          },
          {
            id: 'herpes_encephalitis',
            name: 'Herpes Simplex Encephalitis',
            pathogen: { type: 'Virus', name: '<i>Herpes Simplex Virus 1</i> (HSV-1)', gram: 'dsDNA', shape: 'spherical' },
            epidemiology: {
              incidence: 'Most common sporadic fatal encephalitis',
              risk_groups: ['Anyone (no seasonality)'],
              seasonality: 'None',
              transmission: 'Reactivation (trigeminal ganglion) or Primary infection'
            },
            pathomechanism: {
              steps: [
                'Latent virus reactivates in the trigeminal ganglion and travels retrogradely via nerve fibers back to the brain.',
                'It selectively attacks the temporal and frontal lobes and the limbic system.',
                'Viral replication and immune response cause severe, asymmetric, necrotizing, hemorrhagic inflammation in these areas.',
                'Resulting cerebral edema and temporal lobe swelling can lead to uncal herniation.'
              ],
              virulence_factors: ['Neurovirulence genes']
            },
            clinical: {
              incubation: 'Variable',
              onset: 'Acute (days)',
              symptoms: [
                { name: 'Prodrome', description: 'Fever, headache, malaise for a few days.', severity: 'moderate' },
                { name: 'Behavioral Changes', description: 'Sudden onset of bizarre behavior, personality changes, psychosis, hallucinations (olfactory/gustatory). Often initially mistaken for a psychiatric condition.', severity: 'severe' },
                { name: 'Neurological Deficits', description: 'Aphasia (speech disturbance), hemiparesis, memory loss (especially short-term).', severity: 'severe' },
                { name: 'Seizures', description: 'Common, often with focal onset.', severity: 'severe' }
              ],
              physical_exam: ['Altered mental status', 'Focal neurological signs', 'Memory impairment'],
              complications: ['Uncal herniation', 'Permanent cognitive impairment', 'Death']
            },
            diagnostics: {
              laboratory: [{ test: 'CSF', finding: 'Lymphocytic, elevated RBCs (xanthochromia), elevated protein', interpretation: 'Hemorrhagic necrosis' }],
              imaging: [{ modality: 'MRI', finding: 'Asymmetric hyperintensity in temporal lobe (T2/FLAIR)', significance: 'Pathognomonic' }],
              microbiology: [{ test: 'CSF PCR', finding: 'HSV-1 DNA', significance: 'Gold standard' }]
            },
            therapy: {
              empirical: { inpatient: [{ drug: 'Acyclovir', dose: '10 mg/kg IV every 8 hours', duration: '14-21 days', note: 'Start immediately upon suspicion!' }] },
              targeted: 'Acyclovir IV. Repeat if relapse occurs.',
              supportive: ['Seizure control', 'Cerebral edema management'],
              prevention: ['None']
            },
            prognosis: { mortality: 'Untreated >70%, treated 20-30%', prognostic_scores: [], factors: 'Age, Immune status, Time to treatment' }
          },
          {
            id: 'tbe',
            name: 'Tick-Borne Encephalitis (TBE)',
            pathogen: { type: 'Virus', name: '<i>Tick-Borne Encephalitis Virus</i>', gram: 'RNA, Flaviviridae', shape: 'spherical' },
            epidemiology: {
              incidence: 'Endemic in Central Europe',
              risk_groups: ['Forest goers', 'Tick bite'],
              seasonality: 'Spring-Autumn',
              transmission: 'Tick bite, unpasteurized milk'
            },
            pathomechanism: {
              steps: [
                'The virus enters via the saliva of an infected tick.',
                'Phase 1 (Viremia): The virus replicates in lymph nodes and spleen, causing flu-like symptoms.',
                'Phase 2 (Neuroinvasion): In some patients, the virus crosses the blood-brain barrier and attacks the meninges (meningitis), brain parenchyma (encephalitis), or spinal cord (myelitis).',
                'Spinal cord involvement typically destroys anterior horn motor neurons, leading to flaccid paralysis.'
              ],
              virulence_factors: ['-']
            },
            clinical: {
              incubation: '7-14 days',
              onset: 'Biphasic',
              symptoms: [
                { name: 'Phase 1 (Flu-like)', description: 'Fever, headache, muscle pain, fatigue lasting 2-7 days. Followed by a 1-3 week symptom-free interval.', severity: 'mild' },
                { name: 'Phase 2 (Neurologic)', description: 'Fever returns in 20-30% of patients, with neurological symptoms. Forms: Meningitis (milder), Meningoencephalitis (confusion, ataxia), Meningoencephalomyelitis (paralysis).', severity: 'severe' },
                { name: 'Paralysis', description: 'Asymmetric flaccid paralysis of the shoulder girdle and upper limbs is characteristic (due to anterior horn damage).', severity: 'severe' }
              ],
              physical_exam: ['Ataxia', 'Tremor', 'Flaccid paralysis of shoulder girdle (myelitis)', 'Altered mental status'],
              complications: ['Permanent paralysis', 'Post-encephalitic syndrome']
            },
            diagnostics: {
              laboratory: [{ test: 'CSF', finding: 'Lymphocytic pleocytosis', interpretation: '-' }],
              microbiology: [{ test: 'Serology (IgM/IgG)', finding: 'Blood and CSF', significance: 'Diagnostic (PCR often negative in phase 2!)' }]
            },
            therapy: {
              empirical: { inpatient: [{ drug: 'Supportive', dose: '-', duration: '-', note: 'No specific therapy' }] },
              targeted: 'Symptomatic treatment (edema reduction, rehabilitation).',
              supportive: [],
              prevention: ['Vaccination (FSME-Immun, Encepur)', 'Tick protection']
            },
            prognosis: { mortality: '1-2% (European subtype)', prognostic_scores: [], factors: 'Subtype, time of treatment' }
          },
          {
            id: 'cryptococcal_meningitis',
            name: 'Cryptococcal Meningitis',
            pathogen: { type: 'Fungus', name: '<i>Cryptococcus neoformans</i>', gram: 'Yeast (encapsulated)', shape: 'round' },
            epidemiology: {
              incidence: 'Most common fungal meningitis in HIV/AIDS patients',
              risk_groups: ['HIV (CD4 <100)', 'Transplant recipients', 'Steroid treatment'],
              seasonality: 'None',
              transmission: 'Inhalation (pigeon dropping dust) -> lung -> hematogenous spread'
            },
            pathomechanism: {
              steps: [
                'Fungus enters lungs via inhalation, causing primary infection (often asymptomatic).',
                'In immunosuppression (e.g., AIDS), it disseminates via blood to the brain.',
                'Its thick polysaccharide capsule protects it from phagocytosis.',
                'Accumulation in arachnoid villi blocks CSF absorption, leading to extremely high intracranial pressure without purulent inflammation.'
              ],
              virulence_factors: ['Polysaccharide capsule', 'Melanin production']
            },
            clinical: {
              incubation: 'Unknown (reactivation)',
              onset: 'Subacute/Chronic (weeks)',
              symptoms: [
                { name: 'Slow Progression', description: 'Symptoms develop over weeks. Leading symptoms are worsening headache and fever.', severity: 'moderate' },
                { name: 'High ICP Symptoms', description: 'Due to blocked CSF absorption: visual disturbances (diplopia, blurriness), nausea, altered mental status.', severity: 'severe' },
                { name: 'Absence of Meningeal Signs', description: 'Since inflammatory response is weak (few WBCs), nuchal rigidity is often absent!', severity: 'severe' }
              ],
              physical_exam: ['Meningeal signs often absent!', 'Papilledema (high ICP)', 'Skin symptoms (molluscum-like)'],
              complications: ['High intracranial pressure (blindness, herniation)', 'Cryptococcoma', 'IRIS (at therapy start)']
            },
            diagnostics: {
              laboratory: [{ test: 'CD4', finding: '<100/ÂµL', interpretation: 'Risk' }],
              imaging: [{ modality: 'CT/MRI', finding: 'Often normal, or dilated perivascular spaces, cryptococcoma', significance: 'Exclusion' }],
              microbiology: [
                { test: 'CSF CrAg (antigen)', finding: 'Positive', significance: 'Gold standard (also from blood!)' },
                { test: 'India ink stain', finding: 'Encapsulated yeasts', significance: 'Rapid, but less sensitive' },
                { test: 'CSF culture', finding: 'C. neoformans', significance: 'Diagnostic' },
                { test: 'CSF pressure', finding: 'Often extremely high (>25 cmH2O)', significance: 'Therapeutic tap required' }
              ]
            },
            therapy: {
              empirical: { inpatient: [{ drug: 'Amphotericin B + Flucytosine', dose: 'IV + PO', duration: '2 weeks (induction)', note: 'Gold standard' }] },
              targeted: 'Induction (AmB+5FC) -> Consolidation (Fluconazole 400mg 8 weeks) -> Maintenance (Fluconazole 200mg 1 year/CD4>200).',
              supportive: ['Repeated LP to lower pressure (vital!)'],
              prevention: ['Fluconazole prophylaxis (if blood CrAg positive)', 'Start ART (but carefully due to IRIS)']
            },
            prognosis: { mortality: 'With treatment 10-30%, untreated 100%', prognostic_scores: [], factors: 'Time of treatment, immune status' }
          },
          {
            id: 'naegleria_meningitis',
            name: 'Primary Amoebic Meningoencephalitis (PAM)',
            pathogen: { type: 'Protozoan', name: '<i>Naegleria fowleri</i>', gram: '-', shape: 'amoeba' },
            epidemiology: {
              incidence: 'Very rare, but fatal',
              risk_groups: ['Children/young adults', 'Freshwater swimmers'],
              seasonality: 'Summer (warm water)',
              transmission: 'Water entering nose -> olfactory nerve -> brain'
            },
            pathomechanism: {
              steps: [
                'Water enters the nose during swimming in warm fresh water.',
                'The amoeba penetrates the nasal mucosa and cribriform plate.',
                'It migrates along the olfactory nerve directly to the frontal lobes of the brain.',
                'Multiplying in brain tissue, it enzymatically dissolves and "eats" brain tissue, causing massive hemorrhagic necrosis and edema.'
              ],
              virulence_factors: ['Tissue-degrading enzymes', 'Amebostome (feeding apparatus)']
            },
            clinical: {
              incubation: '1-9 days (average 5)',
              onset: 'Fulminant',
              symptoms: [
                { name: 'Initial Symptoms', description: 'Sudden onset of excruciating frontal headache, fever, nausea. Often preceded by smell/taste disturbances (parosmia/ageusia).', severity: 'severe' },
                { name: 'Progression', description: 'Rapid development of stiff neck, hallucinations, seizures, and coma. Death occurs within 3-7 days due to cerebral edema and herniation.', severity: 'severe' }
              ],
              physical_exam: ['Meningeal irritation', 'Coma', 'Rapid deterioration'],
              complications: ['Herniation', 'Death (within 3-7 days)']
            },
            diagnostics: {
              laboratory: [{ test: 'CSF', finding: 'Purulent (PMN), RBCs, low sugar', interpretation: 'Looks bacterial!' }],
              microbiology: [
                { test: 'CSF microscopy (wet mount)', finding: 'Motile amoebas', significance: 'Diagnostic (but experience needed)' },
                { test: 'PCR', finding: 'Naegleria DNA', significance: 'CDC/Reference lab' }
              ]
            },
            therapy: {
              empirical: { icu: [{ drug: 'Miltefosine + Amphotericin B + Rifampicin + Fluconazole + Azithromycin', dose: 'Combination', duration: '?', note: 'Experimental, few survivors' }] },
              targeted: 'Miltefosine is the key drug. Cooling (hypothermia) may help.',
              supportive: [],
              prevention: ['Nose clip in warm fresh water', 'Nasal irrigation only with sterile water']
            },
            prognosis: { mortality: '>97% (almost always fatal)', prognostic_scores: [], factors: 'Availability of treatment' }
          },
          {
            id: 'brain_abscess',
            name: 'Brain Abscess',
            pathogen: { type: 'Bacterium', name: '<i>Streptococcus</i> spp., <i>Staphylococcus aureus</i>, Anaerobes', gram: 'Mixed', shape: 'Mixed' },
            epidemiology: {
              incidence: 'Rare but serious (0.4-1.3/100,000/year)',
              risk_groups: ['Immunocompromised', 'Chronic otitis/sinusitis', 'Dental infection', 'Endocarditis', 'Head trauma/surgery'],
              seasonality: 'None',
              transmission: 'Endogenous spread (contiguous or hematogenous)'
            },
            pathomechanism: {
              steps: [
                'Direct spread: Infection spreads from adjacent structures (e.g., middle ear, sinus, teeth) to the brain parenchyma (40-50%).',
                'Hematogenous spread: Bacteria reach the brain via the bloodstream from a distant focus (e.g., lung, heart - endocarditis) (25-35%).',
                'Trauma/Surgery: Direct entry following open skull fracture or neurosurgical procedure.',
                'Abscess formation: Bacterial multiplication causes local inflammation (cerebritis), then necrosis. The body attempts to isolate the process with capsule formation.'
              ],
              virulence_factors: ['Synergism of mixed flora', 'Capsule formation']
            },
            clinical: {
              incubation: 'Variable (days-weeks)',
              onset: 'Subacute',
              symptoms: [
                { name: 'Headache', description: 'Most common symptom (>70%), often localized, dull, constant, and progressive.', severity: 'moderate' },
                { name: 'Focal neurological deficits', description: 'Depending on abscess location (e.g., hemiparesis, aphasia, visual field defect).', severity: 'severe' },
                { name: 'Fever', description: 'Present in only 50% of cases! Absence does not rule it out.', severity: 'mild' },
                { name: 'Altered mental status', description: 'Drowsiness, confusion, then coma may develop due to increased intracranial pressure.', severity: 'severe' }
              ],
              physical_exam: ['Papilledema (high ICP)', 'Focal neurological signs', 'Fever (may be absent)'],
              complications: ['Herniation', 'Abscess rupture into the ventricular system (ventriculitis - high mortality)', 'Epilepsy']
            },
            diagnostics: {
              laboratory: [
                { test: 'CBC', finding: 'Leukocytosis (in 60%)', interpretation: 'Unreliable' },
                { test: 'CRP', finding: 'Elevated', interpretation: 'Inflammation' },
                { test: 'Blood culture', finding: 'Positive', interpretation: 'Important in hematogenous origin' }
              ],
              imaging: [
                { modality: 'Head CT/MRI', finding: 'Ring enhancement, perifocal edema', significance: 'Gold standard (MRI is more sensitive)' }
              ],
              microbiology: [
                { test: 'Stereotactic aspiration', finding: 'Pus culture', significance: 'Basis for etiological diagnosis and therapy' },
                { test: 'Lumbar puncture', finding: 'CONTRAINDICATED!', significance: 'Forbidden due to risk of herniation if mass effect exists!' }
              ]
            },
            differential: [
              { disease: 'Brain tumor (Glioblastoma, Metastasis)', distinguishing: 'Imaging (DWI sequence helps), biopsy' },
              { disease: 'Stroke', distinguishing: 'Sudden onset, vascular risk factors' },
              { disease: 'Encephalitis', distinguishing: 'More diffuse, no encapsulated abscess' }
            ],
            therapy: {
              empirical: {
                inpatient: [
                  { drug: 'Ceftriaxone', dose: '2g IV every 12 hours', duration: '4-8 weeks', note: 'Base therapy' },
                  { drug: '+ Metronidazole', dose: '500mg IV every 8 hours', duration: '4-8 weeks', note: 'Anaerobic coverage' },
                  { drug: '+ Vancomycin', dose: '15-20mg/kg IV', duration: '', note: 'If S. aureus suspected (e.g., trauma, endocarditis)' }
                ]
              },
              targeted: 'Based on culture. Prolonged (6-8 weeks) IV, then PO therapy.',
              supportive: ['Neurosurgical aspiration/drainage (if >2.5 cm)', 'Steroids (Dexamethasone) only if significant edema/risk of herniation', 'Anticonvulsants'],
              prevention: ['Treatment of ENT infections', 'Endocarditis prophylaxis']
            },
            prognosis: {
              mortality: '10-20% (improves with early diagnosis)',
              prognostic_scores: [],
              factors: 'Mental status at admission, ventricular rupture'
            }
          },
          {
            id: 'tbc_meningitis',
            name: 'Tuberculous Meningitis',
            pathogen: { type: 'Mycobacterium', name: '<i>Mycobacterium tuberculosis</i>', gram: 'Acid-fast', shape: 'rod' },
            epidemiology: {
              incidence: 'Most common form of extrapulmonary TB',
              risk_groups: ['Immunocompromised (HIV)', 'Individuals from endemic areas', 'Infants', 'Alcoholics'],
              seasonality: 'None',
              transmission: 'Hematogenous spread from a primary lung focus'
            },
            pathomechanism: {
              steps: [
                'Hematogenous Spread: Bacteria spread from a primary lung focus via the bloodstream to the brain/meninges.',
                'Rich Foci: Small, caseating foci (tuberculomas) form in the subcortical or meningeal space.',
                'Rupture: The foci rupture, releasing bacteria and antigens into the subarachnoid space.',
                'Basal Exudate: A thick, gelatinous, inflammatory exudate forms at the base of the brain, encasing cranial nerves and cisterns.',
                'Consequence: Communicating hydrocephalus (impaired CSF absorption), cranial nerve palsies (III, IV, VI, VII), vasculitis, and cerebral infarcts.'
              ],
              virulence_factors: ['Cord factor', 'Intracellular survival']
            },
            clinical: {
              incubation: 'Weeks-months',
              onset: 'Subacute',
              symptoms: [
                { name: 'Prodromal Phase (1-2 weeks)', description: 'Slow, insidious onset: apathy, personality changes, low-grade fever, headache, nausea.', severity: 'moderate' },
                { name: 'Meningeal Phase (2-3 weeks)', description: 'Nuchal rigidity, altered mental status, lethargy, cranial nerve palsies (especially VI, III, IV, VII).', severity: 'severe' },
                { name: 'Paralytic Phase', description: 'Rapid progression to coma, hemiplegia, decerebrate rigidity. Fatal without treatment.', severity: 'severe' }
              ],
              physical_exam: ['Nuchal rigidity', 'Altered mental status', 'Cranial nerve palsies', 'Papilledema'],
              complications: ['Hydrocephalus', 'Cerebral infarction', 'Permanent neurological damage', 'SIADH']
            },
            diagnostics: {
              laboratory: [
                { test: 'CSF', finding: 'Lymphocytic pleocytosis, VERY high protein (>1 g/L), VERY low glucose (<2.2 mmol/L)', interpretation: 'Characteristic triad!' },
                { test: 'CSF ADA', finding: 'Elevated', interpretation: 'Adenosine deaminase, aids in diagnosis' }
              ],
              imaging: [
                { modality: 'MRI/CT with contrast', finding: 'Basal meningeal enhancement, hydrocephalus, tuberculomas', significance: 'Diagnostic' }
              ],
              microbiology: [
                { test: 'CSF Ziehl-Neelsen', finding: 'Acid-fast bacilli', significance: 'Low sensitivity (<20%)' },
                { test: 'CSF Culture', finding: 'M. tuberculosis', significance: 'Gold standard, but slow (weeks)' },
                { test: 'CSF PCR (GeneXpert)', finding: 'MTB DNA', significance: 'Rapid, sensitive' }
              ]
            },
            differential: [
              { disease: 'Cryptococcal meningitis', distinguishing: 'CrAg test, lower protein' },
              { disease: 'Meningeal carcinomatosis', distinguishing: 'Cytology, known tumor' },
              { disease: 'Neurosyphilis', distinguishing: 'Serology, CSF VDRL' }
            ],
            therapy: {
              empirical: {
                inpatient: [
                  { drug: 'RIPE (Rifampicin, Isoniazid, Pyrazinamide, Ethambutol)', dose: 'Standard dose', duration: '9-12 months', note: 'Longer treatment required' },
                  { drug: '+ Dexamethasone', dose: 'IV/PO', duration: '6-8 weeks, then taper', note: 'Reduces mortality! Mandatory!' }
                ]
              },
              targeted: 'Therapy modified based on susceptibility testing.',
              supportive: ['ICP management', 'VP shunt (for hydrocephalus)'],
              prevention: ['BCG vaccine', 'LTBI treatment']
            },
            prognosis: {
              mortality: '20-30% with treatment, 100% without',
              prognostic_scores: ['MRC staging'],
              factors: 'Delay in treatment, level of consciousness, age'
            }
          }
        ]
     }
});
